Results 111 to 120 of about 14,183,490 (208)

Main factors associated with variability in the assessment of the objective response rate. A re-analysis of the PHEREXA phase 3 clinical trial. [PDF]

Br J Clin Pharmacol
Daniele G, Giovagnoli T, Navarra P, Dello Russo C.   +3 more
europepmc   +1 more source

Letter to Editor-response: placebo response rates

eClinicalMedicine, 2023
openaire   +3 more sources

Smartphone App-Based Survey Deployment Patterns and Longitudinal Response Rate: Randomized Controlled Trial. [PDF]

J Med Internet Res
Zhang Y, Rong J, Wang X, Schramm E, Pathiravasan CH, Borrelli B, Faro JM, Benjamin EJ, Trinquart L, Liu C, Murabito JM.   +10 more
europepmc   +1 more source

Factors Impacting the Telephone Follow-Up Response Rate in Patients With Migraine Without Aura: A Cross-Sectional Study of 1299 Females. [PDF]

Pain Res Manag
Na W, Zhao J, Zhang T, Zhou Y, Liu H, Liu Y, Dong Z, Yu S, Wang X.   +8 more
europepmc   +1 more source

Objective response rate targets for recurrent glioblastoma clinical trials based on the historic association between objective response rate and median overall survival. [PDF]

Neuro Oncol, 2023
Ellingson BM, Wen PY, Chang SM, van den Bent M, Vogelbaum MA, Li G, Li S, Kim J, Youssef G, Wick W, Lassman AB, Gilbert MR, de Groot JF, Weller M, Galanis E, Cloughesy TF.   +15 more
europepmc   +1 more source

Evaluation of Pathological Complete Response Rate in Patients with HER2-Positive Breast Cancer Undergoing Neoadjuvant Trastuzumab and Chemotherapy With or Without Anthracycline. [PDF]

Asian Pac J Cancer Prev
Rocha IM, Lustosa AB, Filgueira ABT, Barreto GAV, Alverne LM, Barros Silva PG, Juacaba SF.   +6 more
europepmc   +1 more source

Response rate and long-term survival in patients with advanced melanoma: data from the prospective cohort study gem-1801. [PDF]

Clin Transl Oncol
Espinosa E, Berciano-Guerrero MÁ, Muñoz-Couselo E, Puértolas T, Manzano JL, Soria A, de Miguel PA, Crespo G, Sanz LG, Cerezuela-Fuentes P, de la Rosa CA, Majem M, Castaño AG, Berrocal A, Arroyo FRG, de la Borbolla MR, Bellido L, Martínez JM, Fernández LA, Carnicero AM, Castro RL, Rodríguez AB, Lecumberri MJ, Guzmán JCV, Balea BC, Rodríguez JF, Bautista JV, Pérez VN, Mujika K, Subias MC, Hernández B, Algarra SM, Márquez-Rodas I.   +32 more
europepmc   +1 more source

Raising Response Rates

Epidemiology, 1999
openaire   +3 more sources

Prospects for the application of pathological response rate in neoadjuvant therapy for gastric cancer. [PDF]

Front Oncol
Bao Z, Jia N, Zhang Z, Hou C, Yao B, Li Y.   +5 more
europepmc   +1 more source

Induction Chemotherapy Followed by Immunotherapy Increases Pathological Complete Response Rate in dMMR/MSI-H Gastric Cancer: A Retrospective Cohort Study. [PDF]

Immunotargets Ther
Zeng H, Wu Y, Zhang Z, Liu J, Sun J, Liu X, Gu Y, Tian M, Chen W, Shen Z, Shen K, Xu C, Wang X, Tang Z, Sun Y.   +14 more
europepmc   +1 more source